GK
Gujarat Kidney & Super Speciality Ltd (GKSL)
₹189.61
Mkt cap
₹1,429 Cr
P/E ratio
90.30
P/B
5.93
Div yield
0.00%
ROE
11.10%
ROCE
14.50%
EPS (TTM)
₹2.10
Book value
₹32
52W range
98–210
Sector
Healthcare
Price history
Previous close
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services. [1]
NSE GKSLBSE 544666
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−9.62% from high₹190
₹98+92.77% from low₹210
Current
₹189.61
Prev close
₹189.69
Day
−0.04%
Price performance
1D
−0.04%
1W
+8.45%
1M
+10.55%
3M
+47.05%
6M
+82.72%
1Y
—
YTD
+84.61%
Financials
Revenue, profit & margin
P/E ratio
90.3×
GKSL is 81% above the sector median of 49.8×
GKSL90.3×
Sector median49.8×
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.41 | 11.79 | 9.78 | 15.26 | 12.93 | 23.25 | 30.58 | 34.29 | |
| Expenses | 4.55 | 7.19 | 7.17 | 6.64 | 7.81 | 16.35 | 24.28 | 25.92 | |
| Operating Profit | 4.86 | 4.60 | 2.61 | 8.62 | 5.12 | 6.90 | 6.30 | 8.37 | |
| OPM % | 51.65% | 39.02% | 26.69% | 56.49% | 39.60% | 29.68% | 20.60% | 24.41% | |
| Other Income | 0.04 | 0.05 | 0.05 | 0.01 | 0.09 | 0.06 | 0.71 | 0.69 | |
| Interest | 0.16 | 0.17 | 0.16 | 0.18 | 0.28 | 0.60 | 0.82 | 0.66 | |
| Depreciation | 0.74 | 0.88 | 0.90 | 0.96 | 0.90 | 1.33 | 1.51 | 1.44 | |
| Profit before tax | 4.00 | 3.60 | 1.60 | 7.49 | 4.03 | 5.03 | 4.68 | 6.96 | |
| Tax % | 26.25% | 29.72% | 16.88% | 27.77% | 28.54% | 26.44% | -2.99% | 23.56% | |
| Net Profit | 2.96 | 2.53 | 1.34 | 5.40 | 2.88 | 3.70 | 4.82 | 5.32 | |
| EPS in Rs | 18.39 | 15.53 | 0.23 | 0.85 | 0.47 | 0.37 | 0.64 | 0.66 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202671.45%Promoter
Promoters71.45%
FIIs4.89%
DIIs0.56%
Public23.10%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,944.50 | 61.14 | 1,28,608 | 0.22% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Max Healthcare | ₹1,049.30 | 68.21 | 1,02,129 | 0.19% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| Manipal Health | ₹738.95 | 109.77 | 97,200 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Fortis Health. | ₹886.00 | 62.70 | 66,889 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Aster DM Quality | ₹755.05 | 182.35 | 65,816 | 0.40% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Global Health | ₹1,499.40 | 70.41 | 40,315 | 0.03% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Narayana Hrudaya | ₹1,928.50 | 45.72 | 39,411 | 0.23% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| Gujarat Kidney | ₹181.25 | 90.27 | 1,429 | 0.00% | 5 | +7.02% | 34 | +124.71% | 14.48% |
| Median: 30 Co. | ₹431.67 | 49.80 | 6,085 | 0.01% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Annual reports1
Announcements5
Reg. 34 (1) Annual Report. 19 SepAnnouncement under Regulation 30 (LODR)-Newspaper Publication 4 SepAGM To Be Held On 28-09-2026 3 SepReg. 34 (1) Annual Report. 3 Sep - Revised FY2025-26 annual report filed; 7th AGM on 28 September 2026 with multiple shareholder resolutions.Reg. 34 (1) Annual Report. 3 Sep - 7th AGM on 28 Sep 2026; shareholders to approve director appointments, remuneration revisions and Rs 500 crore borrowing powers.